← Leaderboards
Lainie P Martin
Fox Chase Cancer Center
$1,689,666
Attributed
$1,689,666
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $426.4K · FY2010–22$500K$375K$250K$125K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$1,689,666 · 2
By mechanism
R01$1,326,600 · 1
P50$363,066 · 1
Top collaborators
No co-investigators on record.
Most similar at Fox Chase Cancer Center
Same institution · by research overlap
- Robert C Young$34,163,223
- Paul F. Engstrom$18,067,774
- Andrew K Godwin$21,382,895
- Jose Russo$20,321,995
- Mary Beryl Daly$11,073,226
Others in their field
Top investigators on “Programs”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,641,009,751
- Leonard Freedman · Leidos Biomedical Research, Inc.$994,984,644
- Lawrence Corey · Fred Hutchinson Cancer Center$730,186,538
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Larry Arthur$609,313,548
Research focus
ProgramsComprehensive Cancer CenterMalignant Neoplasm Of OvaryWomanFundingAwardEvaluationGrowthUnited States National Institutes Of HealthDiagnosisMalignant NeoplasmsGrantCancer DetectionCancer CellAscitesDetectionClinicAnimal ModelDiffuseCessation Of LifeCause Of DeathBiochemical ProcessCathepsinsCase Fatality Rates
Grant awards (7)
Career Enhancement Program$106,975
P50 · FY2022 · CA · contact PI
Career Enhancement Program$256,091
P50 · FY2021 · CA · contact PI
Evaluation of In Vivo Optical Imaging in Pancreatic and Ovarian Cancer Patients$147,300
R01 · FY2014 · CA · contact PI
Evaluation of In Vivo Optical Imaging in Pancreatic and Ovarian Cancer Patients$1
R01 · FY2013 · CA · contact PI
Evaluation of In Vivo Optical Imaging in Pancreatic and Ovarian Cancer Patients$426,421
R01 · FY2012 · CA · contact PI
Evaluation of In Vivo Optical Imaging in Pancreatic and Ovarian Cancer Patients$345,304
R01 · FY2011 · CA · contact PI
Evaluation of In Vivo Optical Imaging in Pancreatic and Ovarian Cancer Patients$407,574
R01 · FY2010 · CA · contact PI